Already registered? Need to register? Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

About the PCSK9 Education and Research Forum

PCSK9 Education and Research Forum is the independent resource on PCSK9 science and its translation into critically important new treatments to lower low density lipoprotein cholesterol (LDL-C), which promise to transform the prognosis of millions of patients with hypercholesterolaemia (cholesterol disorders), accelerated atherosclerotic vascular heart disease and a high risk of premature cardiovascular (CV) death and disability.
Aims & ObjectivesMission StatementEditorial BoardPartnership & OutreachForthcoming Meetings
What will members gain?
Most viewed

Targeting PCSK9 inhibition to patients: Highest risk – highest benefit

Report: PCSK9 Forum Editor Professor Derick Raal (University of Witwatersrand, Johannesburg, South Africa) comments on this recent proposal.
Read the report

Video: Is number needed to treat a practical approach to rationalising PCSK9 inhibitor therapy?
Watch the video

Hot Topics

PCSK9 inhibition and neurocognitive effects: weighing up the evidence

Whether lowering LDL cholesterol levels affects cognitive function is a concern with PCSK9 inhibitors. Professor François Mach (Geneva University Hospitals, Switzerland) discusses the evidence, and what new studies add.

Report: EBBINGHAUS counters claim of neurocognitive effects
Read the report
Video: Do the PCSK9 monoclonal antibodies have neurocognitive effects?
Watch the video

From the Editors

PSCK9 inhibitor therapy- after the clinical trials, what can we learn to improve practice?PSCK9 inhibitor therapy- after the clinical trials, what can we learn to improve practice?

Anthony Wierzbicki

After the dust has settled from ACC 2018, Prof. Anthony S Wierzbicki, Guy’s and St Thomas’ Hospitals, London, UK discusses the latest data from the PCSK9 inhibitor trials that will aid risk stratification.

Read the article

FOURIER analysis: consistent benefit across the range of inflammatory risk

Read the article

Meet our Editorial Board

View all our Editorial Board Prof John ChapmanResearch Professor at the University of Pierre and Marie Curie Prof Henry GinsbergDirector, Irving Institute for Clinical and Translational Research Dr Michel FarnierClinician based at Point Medical, Dijon, France Prof Frederick RaalDirector, Carbohydrate & Lipid Metabolism Research Unit Prof Anthony WierzbickiConsultant in Metabolic Medicine/Chemical Pathology